Latest Members


Medicon Valley Alliance is continually adding new 188金宝搏 companies and organisations as members.

These companies and organisations have decided to join forces and strengthen their ties within the region, thereby anhancing their visibility with national and international companies looking at 188金宝搏 in Medicon Valley.

Below is a list of the companies that have recently joined the Medicon Valley Alliance!

Take a look and see if one of them is your new business partner. If you wish to view a directory of all companies and organisations in Medicon Valley – click here!

Latest Members


HEFT Global Life S&T (Shenzen) Ltd. Co.

HEFT Global Life S&T (Shenzen) Ltd. Co. is the HEFT Global Healthcare Holding Group subsidiary. Partnering with Harvard Medical Faculty Physicians and National Cancer Center Japan, the main business is introducing the front edge Biotechnology and Medtechnology into China and localize the application of Medical Image Processing, AI, induced pluripotent stem cells (iPSC) for cancer immunotherapy to meet the growing healthcare demands of the Chinese people.


IDDI is an expert clinical data services and high-level strategic consulting contract research organization (CRO), providing agile clinical trial services for pharmaceutical, biotechnology, and medical device/diagnostic companies. Founded in 1991 by Marc Buyse ScD, IDDI is a global privately-held company with offices in Ottignies, LLN and Raleigh (NC) USA and counts around 130 employees (100 in Belgium and 30 in the USA).
A Therapy-focused CRO: Oncology, Ophthalmology, Cardiovascular, CNS diseases, musculoskeletal and Orphan drugs

EXPERIENCE: 1100+ Phase I-IV Clinical Trials – 20 FDA/EMA Approvals – 4 FDA quoted papers – 850+ Scientific Publications – 750+ Scientific Conferences.

– Innovative clinical STUDY DESIGN including protocol development, choice of endpoints and sample size calculation for conventional, group-sequential or adaptive designs including Bayesian designs.
– Advanced BIOSTATISTICS services: statistical analysis plan, statistical analyses, meta-analysis, statistical inputs to publication and Data Monitoring Committees
– End-to-end comprehensive DATA MANAGEMENT services focusing on the accuracy of clinical data and CDISC regulatory compliance (eCRF design, set-up and validation, data import and reconciliation, medical coding, data export and pooling of databases)
– INTEGRATED TECHNOLOGY : Randomization and Trial supply management (RTSM), Electronic Data capture (EDC) and medical coding.
– REGULATORY Consultancy
o Analytical validation in line with development stage (IDE, IVD, following CLSI)
o Clinical validation: Statistical strategies for 510(k) and PMA studies, bridging studies for companion diagnostics, advanced statistical methodology to validate biomarkers in absence of gold standard.

IDDI’s culture is scientifically driven, thanks to its founder and Chief Scientific Officer Marc Buyse, who is also Professor at Hasselt University, and its main Expert in Biostatistics: Tomasz Burzykowski PhD, who is also part-time Professor at Hasselt University.
15% of IDDI’s projects are academic studies. In this context, it’s no surprise that IDDI has invested in four significant research projects to enhance its capabilities and differentiate in a competitive market:

• BENEFIT (Biostatistical Estimation of Net Effects for Individualization of Therapy)
IDDI – in partnership with Bristol Myers Squibb, the EORTC, the UCL, the University Hospital and Cancer Center of Lyon and with the financial support of the Walloon Region, Biowin – will develop a new statistical methodology (Generalised Pairwise Comparisons – GPC). GPC method will be further develop to usefully complement traditional methods for the design, analysis and interpretation of clinical-trial results and dedicated software will be developed.

• TREATBEST (TREATment of Breast cancer with Epigenetic Specific Tools)
IDDI is one of the partners of this project granted in January 2017 by Biowin, the Walloon cluster of Biotechnology.
Its main objective is to analytically and clinically validate a CE-marked in vitro diagnostic kit based on a DNA methylation signature predicting the benefit from neoadjuvant anthracycline/taxane chemotherapy in previously untreated, non-metastatic, primary triple negative breast cancer patients.
IDDI will perform the Clinical validation of the signature:
o Design, set-up, analysis and reporting of the retrospective study
o Design the prospective
o Statistical support for signature fine-tuning and kit analytical validation

• BRAVO (Biomarker Retrospective Analysis for Validation Optimization)
The BRAVO project was granted by EuroTransbio to IDDI in collaboration with Pamgene, VUMC and I-Biostat.
The objective of this Project was to develop a strategy for more intelligent, faster and cheaper development of diagnostics for Alzheimer’s disease (Novel methodology) based on newly identified/relevant biomarkers.

• SMART (Statistical Monitoring Applied to Research Trials)
IDDI, with the financial support of the Walloon Region, Biowin, developed a statistical software for Statistical Monitoring Applied to Research Trials (SMART) with a view to detecting heterogeneity of data across investigational centers and to create a quality label for clinical trial data). After having invested for over a decade in this research project, IDDI launched early 2012 a unique Central Statistical Monitoring tool based on the SMART™ engine and called CluePoints (visit In 2020, CluePoints offer Sponsors and CROs a better way of identifying, visualizing, managing, and documenting trial risks that could compromise patient safety and delay the approval of Investigational Products. Underpinned by Central Statistical Monitoring, a technique that is currently investigated by the Food and Drug Administration (FDA) for selecting sites for inspection, CluePoints cloud-based products are deployed to support traditional onsite monitoring, medical review and quality to drive a Risk-Based Approach to Study Execution (RBx) and ultimately, to achieve ICH E6 (R2) compliance. CluePoints has become the worldwide leader in central statistical monitoring. Its business model meets the needs of the current COVID-19 pandemic.


ChemoMetec delivers automated cell counters, analyzers, and advanced image cytometers for the biotech, pharma, and academic industries. ChemoMetec instruments deliver the highest level of precision and are 21CFR part 11 ready for secure and traceable operation. Via-Cassette™ technology eliminates user errors from sample handling, counting and analysis. Individual volume-calibration ensures accurate calculation of cell concentration. This eliminates inter-user and inter-instrument variation between your research team, product development, manufacturing, and QC monitoring of end-product. Known for robustness, high precision, and user-friendly interface, our instruments streamline research, process development, and manufacturing processes for maximum efficiency.

Macropage Pharma logo

Macrophage Pharma

Macrophage Pharma Ltd is a private UK based biotechnology company founded in 2016 focused on treating human disease by reprogramming macrophage function through transcriptional reprogramming and targeted drug-delivery leveraging its proprietary Esterase Sensitive Motif™ (ESM™) platform. The proprietary ESM™ is a unique and validated technology platform for delivering active drugs into macrophages and dendritic cells with exquisite specificity resulting in better pharmacology, efficacy and safety for first-in-class drugs against validated targets and biology as well as novel, first-in-class targets.

Kuehne + Nagel

Kuehne + Nagel Denmark has existed since 1955 and has approximately 275 employees at 6 locations with the headquarter situated in Copenhagen. With more than 82,000 employees at some 1,300 locations in over 100 countries, the Kuehne + Nagel Group is one of the world’s leading logistics companies. Kuehen + Nagel´strong market position lies in the seafreight, airfreight, contract logistics and road transport businesses, with a clear focus on high value-added segments such as IT-based integrated logistics solutions.

 Chart Biotech

Chart Bio is with you from science to market. With over 30 years of scientific and commercial experience Chart Bio together with its wide network of experts will prepare your scientific discoveries for commercial success. Not only does Chart Bio have a strong ability to translate and safeguard your science innovation but also identify new innovations and find a way for business growth. Chart Bio has global clients within bioproduction in a range of health applications, with products in early phase of development.  Chart Bio is with you.



Ledidi AS is a health tech company founded in Norway in 2016 by two clinical surgeons and three IT engineers to revolutionize the way data is processed in clinical research and quality registries.
Ledidi has developed PRJCTS a real-time plug-and-play solution for clinical research and quality records. Essentially, Ledidi has brought together all the functionality from registration, analysis, production of graphs and charts to publication, in one unified end-to-end cloud solution that meets both GDPR and HIPAA data security requirements.
The solution is used in both single and multicenter research and radically simplifies international collaboration between researchers in clinical and epidemiological research.
You can sign up and create or import a registry in a few minutes, invite colleagues across the globe and work together in real time without compromising the underlying data. PROM/PREM is included with custom made forms.


Elsevier Life Sciences Solutions serve clients in the pharmaceuticals and biotech, medical technology, chemicals, oil & gas, FMCG, industries and more. Elsevier also serve educators and students in chemistry and health sciences. These clients change the world by fighting disease, improving patient safety, and developing novel materials in ever more sustainable ways. Elsevier enables evidence-based decision making and improved productivity through our unique expertise in curating, enriching, integrating and harmonizing scientific data assets. These data assets are delivered as workflow tools or as unique datasets to which analytics can be applied. As a result, customers can better predict outcomes, mitigate risk, reveal novel discoveries based upon new connections in the data, and more. Each of our offerings — Reaxys, Embase, QUOSA, PharmaPendium, Pathway Studio, Entellect, and Professional Services — are backed by Elsevier’s unique and deep heritage and expertise in data, science, and technology.

GPX Medical AB

GPX Medical was born out of the idea that preterm born babies deserve a better start in life. By providing the neonatal care with a ground-breaking MedTech innovation to continuously monitor the problems these babies suffer from and instantly warn for complications, GPX Medical upgrades the care of our most fragile patients. With a proven spectroscopic technology that measures the lungs’ volume and oxygen content (through probes attached to the baby’s chest), GPX Medical offers a safer, non-invasive method of continuous monitoring of preterm born babies which also saves the baby from pain and suffering.

GPX Medical AB was formed in 2016 as a subsidiary to Gasporox AB (publ) with the aim to develop and commercialize medical applications of the GASMAS technology developed at Dep. of Atom Physics at Lund University. The company is located in Lund, Sweden. 



ALTEN develops and delivers competence for world-leading companies through the most committed engineering and IT consultants. ALTEN help clients within Life science with Manufacturing, Design of medical devices, Regulatory affairs and Pharmacovigilance, Business transformation and digital services.  The ALTEN Group has over 34.000 employees and operations in 29 countries, of which 2000 engineers are working with Life Science.



The PolyPeptide Group is a privately-held Contract Development & Manufacturing Organization (CDMO) which focuses on proprietary and generic GMP-grade peptides for the diagnostic, cosmetic, pharmaceutical and biotechnological market. The Group has manufacturing facilities in Belgium, Sweden, France, India and two sites in the USA. As a multinational company with more than 850 employees worldwide, its diversity brings breadth and depth of knowledge and experience to the Group. The PolyPeptide Group has grown by selective acquisition of existing expertise, culminating in its position today as a leader in peptide manufacturing.

Haeger & Carlsson Executive Search

It is the vioson of Haeger & Carlsson to be the leading recruitment company in the Nordic region in Life Science

Haeger & Carlsson believe in bringing together individuals and organizations that share the same values ​​and goals. This creates the conditions for the individual to succeed and thus contribute to the company’s success. This way of working means that Haeger & Carlsson gains a deeper understanding of both the individual and the client allowing them to identify and find the best and most suitable candidates.

Please contact Håkan Petersson, Senior Recruitment Consultant in Medicon Valley, for more information. tel: +46 706 320 043 


AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience.  In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. 


AGC Biologics

AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics, from pre-clinical to commercial production, using mammalian and microbial production systems.

AGC´s integrated service offerings include cell line development, bioprocess development, formulation, analytical testing, antibody drug development and conjugation, cell banking and storage and protein expression — including our proprietary CHEF1® Expression System for efficient protein production with CHO cells.

AGC´s DNA drives them to provide innovative solutions for clients to reach their goals and accelerate their projects at our cGMP-compliant facilities in the US, Europe and Japan, as well as to facilitate approval and manage spending during the product lifecycle.

AGC forge exceptionally strong partnerships with their clients and never lose sight of our commitment to deliver reliable and compliant drug substance. Right. On Time

WIN Outsourcing Consult

WIN Outsourcing Consult is striving to create business value for biotech, pharmaceutical companies and their CROs/Vendors by making their outsourcing activities, collaborations and expertise more efficient while balancing critical timelines, data quality and study budgets. This is done by utilising  25+ years of best practice R&D and outsourcing experience in the CRO and Pharmaceutical industry and always offer customized services, solutions and advice fitted to each individual customer.

While WIN Outsourcing Consult offers outsourcing advice, services, training and support within both pre-clinical and clinical development, the primary customer base is within the clinical development arena. WIN Outsourcing Consult succeed by making tailored solutions to all our clients within the following categories:

– Clinical outsourcing & contracts management and support – from RFP to study completion

– Negotiations of CRO/Vendor agreements, Work Orders, Costs and rates, GDPR, KPIs etc.

– Training to study teams: CRO/Vendor management, oversight, governance and day-to-day negotiation techniques

– M&A Due Diligence or or Inspection readiness: Quality/business review and gap analysis of CRO/Vendor contracts

– Advice on outsourcing strategies and customized outsourcing models

– Selection of best fit CROs/Vendors and/or long-term collaboration partners

– Development of customised outsourcing templates (e.g. RFP, work order, KPIs, governance charter, outsourcing SOPs)

– Advice, risk assessment, planning and execution of CRO transitioning (“rescuing studies by changing CRO”)

MSD Denmark

Merck & Co., Inc., Kenilworth, New Jersey, USA is known as “Merck” in the United States, Canada & Puerto Rico. We are known as “MSD” in Europe, Middle East, Africa, Latin America & Asia Pacific. We is a global biopharmaceutical leader with a diverse portfolio of prescription medicines, oncology, vaccines and animal health products.

MSD is driven by their purpose to develop and deliver innovative products that save and improve lives. With 69,000 employees operating in more than 140 countries, MSD is proud of their 125 years of service to humanity and continue to be one of the world’s biggest investors in Research & Development.

Longboat Amniotics

Longboat Amniotics was born out of the discovery of novel stem cells in full term amniotic fluid. Research on these cells has demonstrated a number of unique properties in them, highlighting their extraordinary suitability for medical applications. These properties, in combination with safe collection, ethical agreeability, tissue specificity and high cell counts harbour the promise of the exciting journey we have started pushing medical boundaries.

The science and research behind the discoveries on which the company is based has been carried out within the realms of the reputable Lund University in southern Sweden, one of its prime research centers BMC (Bio Medical Center) Research Center, and the university hospital in Lund. Therefore Longboat Amniotics considers itself today to be uniquely positioned to translate stem cell technologies into novel and improved human therapeutics.

The ultimate vision is to contribute to the successful treatment of serious human diseases by providing the very best cells for various regenerative medical applications. The fact that our cells are of neonatal source (and safely retrieved from the amniotic fluid from C-sections) means that they have greater genome integrity. And also other positive attributes of the neonatal source of our cells we suggest will make them superior to traditional sources of stem cells that are currently in therapeutic use.

As part of Longboat Amniotics´ commitment to providing the best cell therapeutics we are developing these for treatments of orphan diseases with high unmet needs in collaboration with international renowend KOL and partners. In a nutshell, Longboat Amniotics has designed and built a complete eco system for managing these cells in a safe, secure and controlled manner, which they are now ready to expand and scale up. The  journey continues. Longboat Amniotics will push the boundaries of science within regenerative medicine to save and improve the lives of many.



Canadian Trade Commissioner Service

The Canadian Trade Commissioner Service (TCS) at the Embassy of Canada in Denmark helps companies navigate the complexities of international markets and make better business decisions. The TCS is on the ground in more than 160 cities worldwide. We gain market intelligence, uncover opportunities for Canadian companies and help reduce business costs and risks. The TCS is a free service of the Government of Canada, helping companies to prepare for international markets, assess market potential, find qualified contacts and resolve business problems.

As part of Global Affairs Canada and of Canada’s network of embassies, the TCS has access to local governments and key business leaders and decision makers in Canada and Denmark. It can increase the credibility of Canadian companies in global markets by helping them gain access to local contacts not readily available to outside businesses, and broker connections to partners, institutions and reseach networks in Canada.


Amgen is one of the world’s leading biotechnology companies. Amgen is a value-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen believes in a “biology first” approach. The company uses cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases.



Testa Center is an open, non-GMP production-like environment/facility and test-bed for education, innovation and proof-of-concept experiments around production of biological products, e.g., monoclonal antibodies, peptides and proteins as well as gene therapy products. Testa Center is a private public partnership making the facility available for the Life Science community in large. The main objective of Testa Center is to promote growth of the Life Science sector and to bridge the gap between discovery and industrialization. Testa Center is owned and operated as a non-profit company by GE Healthcare in Uppsala.

In Testa Center, researchers have access to both equipment and expertise to drive their production process from lab bench scale to industrial pilot scale. The offering includes access to expertise for scaling up experiments for both cell culture (upstream) and protein purification (downstream) for scalability, manufacturability or generation of larger amounts of material.

The facility is designed to be modern, flexible and modular, enabling researchers to perform a wide range of projects covering a complete process or parts of the chain of unit operations. Typically, this could include seed train, bioreactor cultivation, harvest, filtration and protein purification in successive steps.

Testa Center is open for national and international academic and commercial projects. Testa Center was opened in September 2018 and since the start, ten different organizations have executed projects in the Center. Two larger academic institutions (Uppsala University & Royal Institute of Technology, Sweden) have performed projects with the aim at generating larger amounts of material for research as well as extensive educational activities around bioproduction. Several commercial projects have performed projects in Testa Center including mammalian and microbial expression systems for a variety of different proteins.

Prior to entering the execution phase in Testa Center, projects generally go through a longer planning and experimental design phase delineating everything from feasibility, scaling strategy, instrumentation and consumables. The service platform offered is unique in the sense that projects and organizations can work side by side with bioprocessing experts to reduce risk when scaling up and building knowledge around the process.

For cell culturing, Testa Center offers bioreactors from 1-500L for mammalian cells and 1-50L for microbial cultures. For harvest, Testa Center has instrumentation for filtration and as well as batch and continuous centrifugation. For protein purification the Center offers instrumentation from lab bench scale all the way up to pilot- and full-scale production including a variety of column sizes. For a complete instrumentation list, we would like to refer to our web site .

For more information and how to apply for a project, please contact Jesper Hedberg, Director Testa Center (




RhoVac is a pharmaceutical company dedicated to immuno-oncology, signifying that the body’s own immune system is stimulated to identify and destroy cancer cells. The primary focus of RhoVac is to develop a cancer therapy that targets metastases to prevent cancer recurrence and progression after primary tumour therapy.

Pact & Partners International

For over 30 years, Pact & Partners International have been one of the leading global executive search firms, dedicated solely to Life Sciences.

Since the beginnings in 1987, Pact & Partners International has appointed thousands of professionals all over Europe, North America and South America. With headquarters in Copenhagen and offices in Helsinki, Boston, Miami, Paris and London, their global reach is defined by our physical presence as well as their ability to form lasting partnerships with clients and candidates alike. Pact & Partners works as a global team, maintaining weekly communication with all of our partners worldwide to assure we deliver leaders that can accomplish the success you envision.

Their clients range from Fortune 500 organizations to small innovative companies. We assist a great range of public and private companies in recruiting their C-level executives and board members on a global scale. The candidates they place are individuals with extensive international experience, which helps them make organized decisions on global markets.

Within the Life Science industry we fulfill recruitment missions for a wide range of sectors including: Pharmaceuticals, Biotechnologies, Medical Devices, MedTech, Chemistry, Gene and Cell Therapy, Hospitals and Clinics, Cosmetics, Dermatology, Agro-Food and Nutrition, Bioenergy, Biofuel, and the Animal Health Industry. Regardless of the sector, or size of the organization we commit the same level of integrity and dedication to every search we conduct.



Velliv & MVA
Velliv offers particularly attractive pension schemes for MVA-member companies and thier employees.  As part of the MVA  membership benefit programme, MVA has entered into a new framework agreement Velliv, which is far more attractive framework compared to what we have previously been able to offer our member companies, providing you and your colleagues with financially improved pension scheme options and a unique pension ‘DNA’.

For more information about your options of having a company pension scheme with a unique DNA, please contact Velliv via Pension Customer Managers Jesper Krog at or Mads Vallentin at

Leuko3ena AB

Did you know that Allergy is the most common chronic disease in Europe? More than 150 million Europeans suffer from this disease and approximately 45% are likely to be misdiagnosed. Limited access to specialized health care professionals, due to an extreme shortage of Allergologists, is added upon the inadequate level of allergy training given to primary health care. In the US, Allergy is a leading cause of lost workdays compared to both Diabetes and Coronary Heart Disease.

Developed by expert physicians in treating Allergies, our solution increases access to accurate diagnosis and effective treatment by a modern communication tool radically changing the infrastructure of the traditional health care system.


POOW Applications AB

POOW Applications have developed POOW The Food Hero – the app that is a fun and behavioral tool which gives parents support in their struggle to help their children eat. POOW was originally developed to help children with diagnosed eating problems, but in fact a fourth of all children worldwide have eating challenges at some age – and it works for them too! POOW use gamification and bring the child’s own food into the game to encourage the child to eat, making eating with POOW a fun interaction at the dinner table.


Worldwide Clinical Trials

Founded by physicians committed to advancing medical science, Worldwide Clinical Trials is out to change how the world experiences Clinical Research Organizations – in the best possible way. More than 1700 Worldwide professionals provide research services in 60 countries across North and South America, Eastern and Western Europe, Russia, and Asia. This includes full-service drug development services – early phase clinical trials in healthy humans, bioanalytical laboratory services, late phase clinical trials, and post-approval and real-world evidence studies – across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, immune-mediated inflammatory disorders, oncology and rare diseases.


S-cubed is a European company based in Denmark and the United Kingdom offering flexible service solutions: ranging from consultancy, in house support, to full-service CRO capabilities. We specialise in SAS/statistical programming and analysis and have unique medical monitoring capabilities through our Qlik data analytics team. Our CDISC services are at the core of our business and we have been CDISC members for over 10 years. Our Regulatory Affairs team have extensive regulatory expertise encompassing new chemical and biological entities, as well as medicinal products containing established active ingredients, generic compounds and therapies for orphan indications.

S-cubed’s products are industry leading. We offer ‘software as a service’ (SaaS) designed and built using linked data and graph technology. The A3 suite offers an MDR and a Study Workbench created to solve the challenges faced when working with the CDISC standards. Our high quality Qlik extensions are intuitive and work directly from the Qlik dashboard to extend the Business Intelligence functionality and purpose from being read only to an editable environment. We currently have two validated extensions: QommentTM, write-back extension and QompassTM navigation extension.

The staff are carefully selected and experts in clinical data, software development and related processes, with a vast range of experience working in the Pharmaceutical and Healthcare sectors.

Kaiku Health 

Kaiku Health is a health data science company developing personalised digital health interventions in order to improve cancer patients’ quality of life. Currently over 60 European hospitals and clinics are using Kaiku Health to better monitor their patients, reduce manual work and prioritise clinical actions.

Andrew Makin Preclinical Consulting Aps

Andrew Makin Preclinical Consulting ApS

After many years working in the CRO industry, Andrew Makin has now established Andrew Makin Preclinical Consulting ApS. 

Andrew Makin has almost 40 years of practical, hands-on experience in design, management, conduct and overview of preclinical programmes and individual studies. 

He has  broad experience across a wide spectrum of product types within the pharmaceutical, biopharma and medical device industries.  And, being experienced in management and overview of studies including report writing, review and data interpretation, he is ideally placed to help and advise companies both small and large with their preclinical projects.

Having worked with clients and projects in all the major regions of the world, he also has a fundamental understanding of the needs of client companies globally.


Medotemic AB

Medotemic develops mobile systems for motion analysis of asymmetric walking disorders. The system analyzes the walking pattern using the mobile phone’s sensors. The result helps caregivers to evaluate patients progress during rehabilitation while giving immediate biofeedback to the patient.

The problem is that movement disorders often becomes unconscious with consequential problems when the body is unevenly loaded. The system is intended for caregivers, patients or individuals, consisting of web-interface, app and cloud solution.

Progress PR

Progress is a PR company focused on strategic communication and public affairs with offices in Malmö and Stockholm. Progress PR has extensive expierience of working with healthcare and research institutions as well as pharmaceutical companies.


HGF Ltd is one of Europe’s largest firms of Intellectual Property specialists. The firm is one of only a few to offer a fully integrated IP solution, bringing over 200 patent attorneys, trade mark attorneys and IP solicitors together to provide a full-service IP solution. The firm has 21 offices throughout the UK, Ireland, Germany, Austria, The Netherlands and Switzerland.

HGF has a strong group of technology-based strategic business units with experience and expertise covering chemistry, engineering, electronics and 188金宝搏 s. The firm’s multidisciplinary teams of experts include automotive, cleantech, computing and software, energy, food and drink, graphene, medical devices, pharmaceuticals, retail and fashion and healthcare.

Immunovia AB

Immunovia AB was founded in 2007 by investigators from the Department of Immunotechnology at Lund University and CREATE Health, the Center for Translational Cancer Research in Lund, Sweden. Immunovia’s strategy is to decipher the wealth of information in blood and translate it into clinically useful tools to diagnose complex diseases such as cancer, earlier and more accurately than previously possible. Immunovia´s core technology platform, IMMray™, is based on antibody biomarker microarray analysis. The company is now performing clinical validation studies for the commercialization of IMMray™ PanCan-d that could be the first blood-based test for early diagnosis of pancreatic cancer. In the beginning of 2016, the company started a program focused on autoimmune diseases diagnosis, prognosis and therapy monitoring. 

Management Centre Europe (MCE)

Management Centre Europe (MCE) is the leading provider of International Management Development in Europe, Middle East and Africa. Founded in 1961, MCE is part of the American Management Association’s (AMA) Global Network.  MCE has supported the development of more than 500,000 managers in thousands of international companies and organizations through our Open Training Programmes in more than 20 cities including Copenhagen and Customized Learning Solutions (InCompany Training). MCE’s solutions cover the key areas of Leadership, Management and Business Acumen delivered by MCE’s Faculty who are experienced business people from diverse industries and countries.



Catalyze is a market leader in obtaining funding for biomedical and healthcare innovations. Catalyze helps leading researchers, SME’s and companies to secure financing for ambitious R&D projects, from early stage pre-clinical research up to clinical stage development and beyond. Catalyze provides funding consultancy and related services to selected, meaningful and innovative projects. The company aims to make sure that these projects are securely funded and that the research and development strategy is geared to a maximum chance of success. Catalyze supports a variety of Life Sciences developments including, but not limited to, healthcare solutions, medical devices, diagnostics, pharmaceuticals, Agri-Food and Bioeconomy. The company has a strong passion for the latest technological innovations and its top consultants work with the best clients and projects in Europe and beyond. 



Medow AB 

Medow works with product development, specializing in health care products.  Medow believe that the health care environment is way too dull and complicated and therefore they offer simple and colourful solutions to the small problems with big impact. Their first product IV-bracelet, is an easy to use bracelet to which intravenous tubes can be attached, to keep them and the vascular access device in place during various kinds of treatments. The bracelet gives the patient a safer and comfortable treatment and at the same time eases the nurses’ work.


PerkinElmer, Inc.  enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, PerkinElmer delivers unique solutions to serve the diagnostics, 188金宝搏 s, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Their dedicated team of 12,500 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the well-being and longevity of people globally.


Polish Investment & Trade Agency

Polish Investment and Trade Agency is a governmental agency assisting Polish companies with export and investment promotion services. Polish Investment & Trade Agency also serves as a one-stop service for foreign companies looking to set up or expand business activities in Poland.

Farmantra S.L.

Farmantra is a 188金宝搏 s corporate finance advisory mainly focused on :

  1. StrategicCFO Services

Unlike classical CFOs that are more focused on finance controlling, Farmantra is are more strategic and analytical which is vital for a young Biotech/MedTech where they assist the CEO in maximising value in the long term. As an Interim CFO, we take following responsibilities:

  • Managing risks and uncertainties: Future should not be viewed as a fixed outcome rather a range of possibilities and on the basis of insights into their respective likelihoods, as a probability distribution
  • Making Decisions: We assist the CEO and the board in making decisions using tools such as Decision Trees and Simulations
  • Investor relations: Evaluate the best outcomes and assist in funding rounds, licensing deals and secondary offerings
  • Corporate governance: Present to the board key financial and non-financial metrics
  1. Early Stage Valuation

At early stage, you have less historical data, higher uncertainties and risks and hence a good early stage valuation should have the right narratives backed by numbers.

Farmantra has valued several early stage assets and helped the companies in structuring the licensing deals. While valuing early stage assets, we collaborate with several KOLs and experts that provide high quality inputs to the assessment.

In addition, Farmantra has given talks on early stage valuation at the following forums:

  1. Karolinska Innovation and Smile incubator in Sweden
  2. DANSK BIOTEK, Copenhagen
  3. Aleap, Oslo
  4. CFA Society Switzerland – Geneva and Zurich

Lumito AB

Lumito is a company that specializes in medical research and development imaging technology. The technology based on so called Upconverting Nanoparticles (UCNP) aims to increase the image quality in biomedical imaging techniques.
Lumito’s patent includes creating high resolution tissue images in for example tumours, together with nanoparticle markers. The technology has several potential areas of use, but Lumito has primarily chosen to focus on digital pathology.


Minerva Imaging

Minerva Imaging is a scientifically driven CRO founded in 2011. Their services are currently focused on advanced oncology models, radionuclide therapy and cardiovascular disease combined with various imaging modalities for translational research and drug development.

Minerva´s capabilities include

  • Extensive experience in design and execution of pre-clinical studies for drug development within oncology and immuno-oncology.
  • Substantial experience with targeted radionuclide therapy in oncology, include testing of alpha- and beta-emitting ligands in subcutaneous, orthotropic or metastatic cancer models.
  • Proficiency in conducting molecular imaging studies with a translational focus.
  • Imaging of pathophysiology in cardiovascular disease, using relevant animal models of cardiovascular disease and longitudinal study designs to follow therapeutic interventions by non-invasive imaging.
  • Clinical translation to Phase I/II studies including clinical trial design and execution in collaboration with our clinical partners.

Minerva´s competences build on more than two decades of research within oncology, cardiovascular disease and molecular imaging performed at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark.




BioGaia is an innovative Swedish healthcare company and has been a world-leader in dietary supplements with probiotics for nearly 30 years. Over the years BioGaia has created networks of leading, independent researchers and specialists, manufacturing experts and local distribution partners worldwide. Their products are recommended by pediatricians and other healthcare professionals in more than 100 countries.

BioGaia’s products contain Lactobacillus reuteri, a probiotic bacteria that helps good microorganisms restore a natural balance in the gut. L. reuteri is one of few bacteria that has co-evolved with humans and because of this it naturally colonizes and has a strong adaptation and interacts with us. To date L. reuteri has been tested in 203 clinical trials (February 2019) and proven effective and safe in children and adults.

BioGaia wants to contribute to better health in the world by offering clinically-proven and user-friendly probiotic products


Sigma Connectivity AB

Sigma Connectivity is a design house and consultancy in one, and has since being acquired from Sony Mobile in 2013, successfully increased the number of active engineers from 180 to over 500. With the R&D investments Ericsson made in Lund during the 80s and 90s, Sigma Connectivity partner up with world-leading organizations, continually pushing the boundaries of technology to deliver connected solutions. In addition to delivering complete Hardware and Software solutions our focus areas Consumer Products, Industrial and Systems we now also offer full Medical Technology services.

Bioinicia SL

Bioinicia changes the way poorly bioavailable drugs are formulated. Bioinicia is a specialty CDMO with drug delivery solutions to address low bioavailability of active pharmaceutical ingredients (API).

Bioinicia´s proprietary, low-temperature encapsulation technology produces ultrathin fibres or fine particles. APIs are processed into highly dispersed, submicron particles of amorphous form within polymer matrices. Fibre/particle matrices are selected to provide optimized release of the bioactives. Their fibre/particle products seamlessly integrate with standard industrial tabletting or film processing technologies.

Bioinicia’s technology is currently being used in the production of patches for transdermal/transmucosal administration, for tablet pressing for oral administration and sprays for inhalation.

Venn Life Sciences

Venn Life Sciences is an Integrated Drug Development Partner offering a unique combination of drug and device development expertise and clinical trial design and management. This enables us to create, plan and execute drug and medical device development programs effectively and seamlessly for our clients.  Our team of European Experts have international experience of guiding organizations through each stage from discovery to market.  Venn Life Sciences partners with other qualified and validated suppliers, providing a truly international coverage. We have a global client base including academia, non-profit organisations, large Pharma, emerging, virtual and biotech companies.

Lead Agency

LEAD Agency is a full-service Public Relations and Public Affairs agency, based in Copenhagen. LEAD has a strong market position in Healthcare and Life Science and a profound track record in a broad range of therapeutic areas, diagnostics, medico and biotech. Services in Healthcare and Life Science include political analysis, stakeholder management, brand and communication strategies, co-creative policy making and digital communication – and with a long experience in the facilitation of partnerships and alliances. LEAD has a dedicated healthcare team of academic specialists within political science, business strategy, communication and journalism. Clients include a wide range of Danish and international companies, organizations, public institutions and patient organizations.

BioInnovation Institute 

BioInnovation Institute (BII) is an international hub for research-based innovation and entrepreneurship and embraces every development phase of early-stage 188金宝搏 start-ups within biotech, pharma and medtech. In BII, projects have access to a vibrant 188金宝搏 community and 2,300 square meters of state-of-the-art lab and office facilities, business acceleration programs, start-up business incubation, commercial support, unique funding opportunities and access to high-level mentoring and international networks. For the first three years of operations, BII has been granted DKK 392 million by the Novo Nordisk Foundation to bring ideas to life and research to market. BII is located in Copenhagen Bio Science Park (COBIS) in Copenhagen, Denmark. Read more on the BII website.

IO Biotech

IO Biotech is a clinical stage biotech company developing disruptive immune modulating anti-cancer therapies. The company is focused on development of immunological treatment of cancer with a research profile based on successful R&D discoveries, translated into numerous clinical trials.

IO Biotech has achieved a proven track record of progressing pre-clinical and clinical compounds:

  • Two lead anti-cancer therapies targeting IDO and PD-L1 are in clinical development
  • Several compounds finalizing preclinical phase

IO Biotech is located in Copenhagen and was founded in December 2014 as a spin out from the Centre for Cancer Immune Therapy (CCIT), University of Copenhagen Herlev Hospital, Denmark. CCIT provides the infrastructure of certified clinical grade laboratory for preparation of therapeutic products.


Effector is a full-service agency, specialized in healthcare communication. From our offices in Copenhagen, Stockholm and Bergen; and with specialized partners in Helsinki we help you navigate Nordic healthcare and achieve your business objectives. Based on an in-depth understanding of the complex healthcare stakeholder system in each country, Effector delivers solutions that change attitudes and behaviors, leading to improved results. Among the clients you will find global pharma and medtech companies, medical associations, patient associations and public agencies. 

Aventur AB

Aventur AB is a research-based company in the field of food – nutrition – biotechnology. The core activity is the development of scientifically verified products and processes for functional foods and adjacent spheres. Aventur´s competence stretches all the way from research to finished products.

CanImguide AB

CanImguide AB is pioneering immuno-oncology with an entirely novel, proprietary treatment concept that restores the capability of the natural immune system to fight cancer.

HB Medical 

HB Medical is the partner-of-choice for the world’s pharmaceutical, medical device and cosmetic companies.HB Medical offers contract manufacturing services and a complete supply chain solution, from the initial concept to the finished product.HB Medical has the know-how and drive to make your product succeed. HB Medical is GMP, GDP and ISO:13485 certified.

Their specialized and professional staff can accommodate all different types of clients with taylor-made services related to clinical trial supply such as planning, forecasting, randomization, sourcing for comparators, packaging and labelling, storage and QP release

They also offer a long range of consultancy services within  GMP,  GDP, Clinical Supply Management, Product and Proces Validation, CMC and Quality Management Systems.

Danish Diabetes Academy (DDA)

The DDA is a networking and educational platform funded by the Novo Nordisk Foundation. Its mission is to educate and train the next generation of researchers in the field of diabetes.

The overall objectives of the DDA are to:

  • Strengthen the research training available to PhD students and postdocs within the field of diabetes, in collaboration with academia, hospitals and the life-science industry.
  • Serve as a national hub within diabetes, unifying academia, hospitals and the life-science industry in Denmark to strengthen educational activities and talent development within the area
  • Recruit outstanding national and international PhD students, postdocs and visiting professors within the field of diabetes, in open and free competition

In collaboration with national and international universities and the life-science industry in Denmark, the DDA will organise up to 20 annual educational activities and 10 annual networking events and allocate a number of grants for PhD scholarships and postdoc fellowships including industrial PhD scholarships and industrial postdoc fellowships.

The DDA is always pleased to invite new stakeholders into the community. At their website, you can join the DDA or sign up for the monthly newsletter.


bulb INTELLIGENCE  is a competitive intelligence company. bulb INTELLIGENCE provides high quality intelligence services primarily in the 188金宝搏 area.

In the process of developing your business, it is imperative to understand the competitive landscape. This landscape includes competitors, new emerging products and evolving trends that might have an impact on your business. A description and ANALYSIS of the landscape give you possibility to optimize your business strategy.

bulb has long standing experience from identifying different competitive landscapes, to analyze different scenarios and defining key company strategies. bulb guides you to improve your business by providing a structured understanding of both your competitive edge in the market place  as well as  your business challenges.

Clinical Microbiomics

Clinical Microbiomics is a ISO/IEC 17025:2005 certified contract research organization specialized in microbiomics and innovative bioinformatics concepts. Clinical Microbiomics offer end-to-end microbiome research services including DNA-extraction, library preparation, sequencing and bioinformatic and conduct shotgun metagenomics analyses using the metagenomic species (MGS) concept, which facilitates high-resolution metagenomics analysis, far beyond classical reference-based approaches. Through customized analysis, Clinical Microbiomics´ proprietary bioinformatics MGS platform and a continuous innovation pipeline they provide their partners with leading capabilities to analyze and interpret microbiome metagenomics data, including ultra-high SNV-level microbiome profiling and Functional Species Group association analyses.

River Stone Biotech

River Stone is a synthetic biology venture with a focus on pharmaceutical applications.  River Stone work in 3 areas:   a) Improving the production and utility of CNS targeting products, with an initial focus on alkaloids,  ii) The production of small molecule bioactives in-situ in humans, iii) The provision of synbio tools and libraries to others. The River Stone team contains some of the pioneers of commercial synthetic biology, and has successfully taken synthetic biology products all the way from idea to full scale product launch multiple times.   River Stone integrates molecular biology, analytical chemistry, biochemistry, synthetic chemistry, fermentation, purification, scale-up, ADMET and regulatory aspects.  The main research effort is based in Copenhagen, with financing primarily from the USA.


At Ecozyme, the focus is to develop the Biocatalytic and Biorecognition industry. ecozyme guides clients all steps of the way for their biocatalytic applications – from ideal enzyme selection and optimal cloning for maximal yields, to fermentation and downstream processing. In addition, ecozyme also offer consultation for application-specific immobilization.

Ecozyme also specializes in developing electrochemical biosensors using custom enzyme and protein receptors. The aim of ecozyme is to develop novel and innovative detection and diagnostic methods to bridge the gap between bench-top immunoassays and reference diagnostic methods

Nordic Nanovector

Nordic Nanovector is a biopharmaceutical company dedicated to extending and improving the lives of patients with haematological cancers through the development and commercialisation of innovative targeted therapeutics.

The company’s lead clinical-stage product is Betalutin®, the first in a new class of antibody radionuclide conjugates (ARCs), designed to improve upon and complement current options for the treatment of non-Hodgkin lymphoma (NHL). NHL is an indication with substantial unmet medical need and orphan drug opportunities.

Betalutin® is a tumour-seeking anti-CD37 antibody conjugated to a low-intensity radionuclide (lutetium-177). It is showing promising efficacy and tolerability in a Phase 1/2 clinical study in a difficult-to-treat NHL patient population.

The company aims to develop Betalutin® for the treatment of patients with relapsed/refractory NHL.

Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets, while exploring potential distribution agreements in selected geographies.

Nordic Nanovector is committed to building a pipeline of novel ARCs and antibody drug conjugates (ADCs) addressing multiple selected haematological malignancies based on proprietary technologies and expertise, and with technologies from partners where complementary.




SoftOx Solutions is a Scandinavian Medtech company established in 2012 with a mission to solve some of the world’s biggest challenges to human health – recalcitrant biofilm infections and antibiotic resistance. Their proprietary technology is a unique combination of antimicrobial agents with broad-spectrum activity and increased tissue tolerability. It effectively kills free-living bacteria and biofilms, which are aggregates of bacteria notorious for being highly resistant to antibiotics of all kind. It kills bacteria by targeting multiple microbial components, making it unlikely for bacteria to develop resistance to the technology or cross-resistance to other antibiotics.

In hospital or community settings, extensive amounts of antibiotics are used both systemically and topically without being able to eradicate biofilm infections. SoftOx is focused on developing our technology into clinically proven antimicrobials for topical application to prevent and control difficult-to-treat biofilm infections and to reduce inappropriate use of antibiotics and the emergence of antibiotic resistance. To achieve these goals, SoftOx has employed a competent team and established partnerships with expert scientists and clinicians from the University of Copenhagen and Bispebjerg Hospital in Denmark. Together this team is devoted to ensure successful clinical implementation of SoftOx’ products. 


chart Biotech

chart biotech´s ambition is to contribute to a strong and sustainable Biotechnology industry. They do this through their services to companies of all sizes and guises, helping them chart a way forward and reach their development goals. chart Biotech operates within the following areas: corporate and business development strategy, product portfolio, stakeholder strategy and strategic network building.

Their current portfolio of projects includes the following areas: bioproduction, natural products, drug delivery, medical technology/devices that incorporate sensors.


Gospel PR AB 

Gospel PR is a Swedish strategic communications agency specialized in public relations, public opinion and market communication.  Gospel PR crafts and executes integrated communication solutions that exploit the full potential of third-party endorsement and a shared, compelling value story. Gospel PR has more than 25 years’ experience of working within the complex environment of health care and the 188金宝搏 industry. Throughout the years they have built a network of communication agencies in the Nordics and the rest of the world, with an excellent track record and deep understanding of the local market.



RTC is a leading CRO in Europe with more than 40 years of experience providing high quality in nonclinical research to national and international pharmaceutical companies and health-related organizations. RTC has been fully accredited by AAALAC. The company offers a full range of experimental and consultancy services, performed by experts in the development and safety assessment of: Pharmaceuticals (Small molecules, Biologicals), Medical Devices, Veterinary Drugs, Food Products (Novel Food, Food Additives and Food Ingredients), Chemicals, Agrochemicals, Biocides. For each class of products, studies are performed according to international guidelines and regulations. RTC high standard quality is guaranteed through European, American and Japanese authorities’ approval.


eVision Industry Software creates best-in-class Control of Work software. Innovative solutions that improve the way companies like Shell, Total, BP, Statoil, RasGas, and many others operate on a global and local scale. eVision enables you to increase the safety and speed of hazardous operations, supporting you in reaching your operational excellence and safety objectives. With offices worldwide and partnerships with the world’s leading system integrators, eVision provides high-quality delivery and support, on location, at all times. 


 Daiichi Sankyo

Daiichi Sankyo and its 15,000 employees in more than 20 countries are dedicated to the creation and supply of innovative pharmaceutical products. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, the Group’s 2025 vision is to become a “Global Pharma Innovator with Competitive Advantage in Oncology”. The European headquarters are in Munich, Germany and we have affiliates in 12 European countries.  



Santax Medico

Santax Nordic is service-level company in Copenhagen and supports our activities in Denmark and Sweden (Norway and Finland). Santax Medico is concerned with medtech manufacturers and help them establish themselves in the Nordic Market. We perform; Marketing, Sales and Service for international Med-Tech companies. Our main suppliers are from USA, Japan, Germany, China, Sweden and Denmark.

AFYX Therapeutics

AFYX Therapeutics is changing the way mucosal diseases are treated. AFYX Therapeuticsis  a topical drug delivery company developing a pipeline of targeted treatments for conditions that currently lack approved therapy options.

Their proprietary Rivelin® patch is flexible, biodegradable, and adhesive to mucosal surfaces. Designed with electrospinning technology, it delivers a therapeutic directly to the site in need, without interfering with patients’ daily activities.

Rivelin patches are compatible with a multitude of active pharmaceuticals, fueling our pipeline of products that seek to deliver relief through targeted, continuous therapeutic delivery to mucosal tissue. Their  lead program, Rivelin-CLO, is in late-stage clinical trials for oral lichen planus, a condition that affects more than 6 million people.

Led by a global team that has brought seven new topical products to market, AFYX Therapeutics is creating a new treatment paradigm for mucosal diseases by providing the first medicines that stick.

Thyrolytics AB

Thyrolytics is developing a first-of-its-kind diagnostic device for thyroid disorders. Their technology implies a one-step direct measurement  of the serum levels of free T4 and T3 at efficient cost, short time and is assembled in a bench-top device format.


Resanitec offers comprehensive clean room and biosafety cabinet testing, certification and related services including environmental monitoring, airflow, HEPA filter integrity, Particle level, air exchange rate and clean room training.

Resanitec has vast experience in cleanroom systems in order to help ensure these critical areas are performing in accordance with international standards and customer quality specifications. Resanitec cleanroom testing and certification services are executed in accordance with Standard Operating Procedures (SOPs), in compliance with current Good Manufacturing Practices (cGMPs) and International Organization for Standardization (ISO). All samples are analyzed at own microbiology laboratory at the Ideon Science Park in Lund.


Technia AB 

TechniaTranscat is a global leading knowledge company within PLM. With offices all over the world, they are just as much a global system integrator as a local partner. The commitment to there clients continues to be delivered by engineers who have both detailed engineering expertise and an extensive understanding of the PLM solutions and different Industries.

With a long experience of working with companies within the Life Sciences Industry. They have the awareness about the challenges in the Life Sciences industry; a constant search for new ways to reduce time to market, decrease launch time of new products, streamline processes, make the packaging process less complex, increase revenues and cut cost and at the same time meet regulatory demands.

TechniaTranscats expertise is to help companies to drastically reduce product development costs and deliver products to market much faster than the competition – while enabling you to meet regulatory compliance – through smart use of Product Lifecycle Management (PLM) systems.

They have 600 consultants that are experts in ENOVIA®, CATIA®, SIMULIA®, BIOVIA® and DELMIA®, and have experience from working with over 5000 clients worldwide, many of them listed on the Fortune 500. TechniaTranscat is a part of Addnode Group, listed at the Nasdaq OMX Nordic List.



HalioDx is an immuno-oncology diagnostic company providing services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies.

Thanks to the pioneering work of Jérôme Galon, HalioDx provides a unique range of immune scoring solutions based on the analysis and the understanding of the immune contexture of tumor, a key determinant of patients’ outcomes and response to cancer treatment.

Conducted in a Research or GCP/GCLP environment, the HalioDx Clinical Research tests are now part of cancer Immunogram, a multi-parameter approach that offers a personalized and dynamic “fingerprint” of tumor-immune system interaction.

HalioDx has an experienced team of more than 130 employees, a CLIA-certified laboratory and compliant facilities to develop, manufacture, register and market in vitro diagnostic (IVD) products. HalioDx executes biomarker studies and companion diagnostic assay development in conformity with regulations and in partnership with biopharmaceutical companies.


Shenzhen Bao‘an Traditional Chinese Medicine Hospital Group

Shenzhen Bao’an Traditional Chinese Medicine Hospital Group is a well-established medical institution that includes a general hospital (Shenzhen Bao’an TCM hospital), a branch hospital (Acupuncture and Rehabilitation Hospital) and 13 community health service centers. The group aims to build a modern traditional Chinese hospital with a tertiary network of Chinese medicine and a hierarchical medical system. The group plans to have a general hospital, 5 branch hospitals and 50 community health service centers in the future.

After 30 years development, the general hospital of the group has become a Third-level grade-A TCM hospital that possesses the functions of medical care, science research, education, preventive medicine, health care and rehabilitation. Now, it has developed as the Guangdong Famous TCM Hospital, National standardized training base for resident doctors of Traditional Chinese, National standardized training base for resident doctors of General Medicine, Guangdong and Shenzhen Postdoctoral Innovation Practice Base, Guangdong Chest Pain Center and ShenZhen Stroke Center.


Phase Holographic Imaging AB

Phase Holographic Imaging AB (PHI) provides researchers in academia and the 188金宝搏 s industry with products for live-cell kinetic studies. PHI’s time-lapse cytometer, the HoloMonitor® system, is based on our core technology holographic microscopy.

Since introducing the first instrument in 2011, PHI now offers a range of products for the label-free, long-term quantitative analysis of living cell dynamics, circumventing the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors.



Quintiles and IMS Health have come together to become IQVIA, The Human Data Science Company™

IQVIA commits to providing solutions that enable 188金宝搏 s companies to innovate with confidence, maximize their opportunities and ultimately drive human health outcomes forward.

IQVIA provides actionable solutions by tapping into the power of the IQVIA CORE™:

  • Domain Expertise. Institutional knowledge and domain expertise across diseases, geographies and scientific methods
  • Advanced Analytics. Faster, more precise decision-making generated by advanced analytics designed for healthcare
  • Unparalleled Data. One of the world’s largest curated healthcare data sources with innovative privacy protections
  • Transformative Technology. Leading technologies to provide real-time access to operations-critical information

 IQVIA has approximately 50,000 employees working in offices in more than 100 countries. We have offices in all four Nordic countries with approximately 450 employees who help authorities, interest groups, pharmacies, hospitals, and companies in the pharmaceutical industry and medtech to gain new insights and in-depth knowledge.



GN Resound

GN Hearing A/S is part of the GN Group, a global leader in intelligent audio solutions that let you hear more, do more and be more than you ever thought possible. Our unique portfolio of medical solutions – and the deep research & development expertise behind this range of products gives our brands unprecedented advantages in the med-tech, hearables and intelligent audio field. Every day, we transform lives through the power of sound with Smart Hearing aids that enhance the lives of people with hearing loss to be more productive.

With world leading expertise in the human ear, sound, wireless technology and miniaturization, GN’s innovative products are marketed via our various brands and solutions to users in more than 90 countries across the world under the ReSound, Beltone and Interton brand names.

Founded in 1869, the GN Group today has 5,400 employees and its parent company, GN Store Nord, is listed on NASDAQ Copenhagen (GN.CO).



Redoxis is a Swedish CRO with a core competence and experience in preclinical models for autoimmune and inflammatory conditions. We provide a wide range of in vivo and in vitro models validated with standard reference therapies. Our models are excellent tools for investigation of therapeutic efficacy and MoA of novel therapies.

Redoxis performs tailor-made preclinical studies combining dedication, experience and agility to provide reliable results to your project.

Potter Clarkson LLP

Potter Clarkson LLP is an award-winning, top-tier firm of European patent and trade mark attorneys and IP lawyers, and one of the largest full service intellectual property practices in Europe.

Advising clients around the globe on intellectual property rights across a variety of industry and technical sectors, we are well-known for handling some of the most complex and challenging patent and trade mark cases, and are particularly well-regarded for our successful prosecution, opposition and appeal work.

Our proven excellence and commercial expertise has made us the European firm of choice for several global giants, household names, universities and SMEs, as well as smaller companies and individuals all of whom wish to benefit commercially from their investment into intellectual property. Furthermore, we can assist with all international IP issues through our associations with top attorney firms worldwide.

Originating in Nottingham, Potter Clarkson also has offices in London, Munich, Copenhagen, Stockholm and Lund. We have worked with companies in Scandinavia for over 30 years, and the office in Copenhagen, alongside the office facility in Lund, enables us to offer our full services within the Medicon Valley region.

In terms of Life Sciences, we operate one of the largest departments in Europe, with more than 35 specialists working in our Biotechnology and Pharmaceuticals group. As well as being a highly-respected firm of traditional patent and trade mark attorneys, many recognised as leaders in their field, the firm’s Dispute Resolution and Commercial team offers the full range of IP litigation services in all English courts of law, as well as all non-contentious, commercial legal services associated with IP.

Our goal is to work closely and strategically with our clients to ensure that they gain the most commercial benefit from their investment in IP.  


Scandion Oncology


Omron Electronics A/S

McNeil AB


Albright Life Sciences A/S 

Albright Life Sciences A/S is a top-tier and AAA rated executive search and leadership consulting company, and one of the largest Life Science-focused executive search firms in the Nordic region. We serve global- and local clients within the Life Science industry – delivering tailor-made solutions sensitive to their specialization, their organization and the specific challenges they are faced with.

As a founding member of Global Life Science Alliance (GLSA) and member of AESC (Association of Executive Search Consultants), Albright is governed by the highest standards and has a global reach of more than 70+ countries.

Albright is built on a single ambition: ‘To search, assess and recruit high caliber executives to the Life Science industry who are capable of generating significant competitive advantages to our clients’. We achieve this by delivering unparalleled and highly specialized industry expertise, comprehensive local market knowledge, and global reach capabilities. 

ReceptorPharma AB

ReceptorPharma is a young orphan receptor drug discovery company that is developing new drug candidates for neurodegenerative disorders, by utilizing recent discoveries in the expanding field of orphan G Protein-Coupled Receptor (GPCR) pharmacology and combining them with new knowledge into neurodegenerative disease mechanisms.

Our long-term goal is to create new medicines for many more disease states, using the therapeutically underutilized family of orphan GPCRs as drug targets. Literature searches suggest that 80% of all orphan GPCRs, of which there still are about 80-100 in the human genome, are strongly correlated to disease. This makes them highly interesting to us and we consider them the drug targets of tomorrow.


Mercodia – when accuracy matters

Mercodia provides biomarker immunoassays and services for clinical and research applications, notably within diabetes, obesity and cardiovascular disease. We service a global market of over 100 countries with immunoassays spanning nine different species, covering both the basic and clinical research sector.

Mercodia – immunoassays and services

Mercodia also offers GLP-compliant outsourcing services for preclinical and clinical studies. Our bioanalytical, development, and production services are guided by industry guidelines, an extensive quality system (MAQS) and ISO 13485 for manufacturing medical devices. We specialize in large molecule ligand-binding assays, PK/ADA/PD/TK analysis, and offer a unique expertise in product life cycle management.

  • Market-leading quality immunoassays (
  • Offers custom development and production
  • Excellent track-record in optimization of customer assays
  • Experts in bioanalysis and validation (FDA/EMA – PK/ADA/PD/RUO)


Eurofins Amatsigroup

Eurofins Amatsigroup is a leading international Contract Development and Manufacturing Organization (CDMO) based in Europe. Our company focuses on drug product development for chemical/biological entities and drug substance development for biologics.

We support small and major biopharmaceutical companies in an innovative way to help them achieving their (pre)clinical milestones timely.

Our solid track record in developing and manufacturing New Biological Entities (NBE)/New Chemical Entities (NCE) is one of our strongest asset.

We are experts in breakthrough technologies for highly potent compounds, poorly soluble drugs, lyophilisation processes and specific therapeutic areas (immunotherapies, orphan drugs, pediatric dosage forms…). Our facilities are perfectly designed for small clinical and/or commercial batches either for sterile or non-sterile dosage forms.

Involved in the earliest steps, our highly-qualified project management team will propose a complete drug development strategy in compliance with regulations.

Frequent communication through one single point of contact, flexibility, troubleshooting mindset, customized solutions, will help our clients to speed up their drug development process.

Our goal is to build a sustainable partnership with our customers to support their drug development pathway.

Eurofins Amatsigroup: your CDMO partner for full drug development on innovative molecules.


Our services:


Preclinical and early clinical development

Clinical and small scale manufacturing (GMP)

Clinical trial material (packaging & logistics)

Global project management ǀ CMC – RA


Contact us:




Miltenyi Biotec

Miltenyi Biotec, is committed to empowering scientific discovery and impacting human lives. For more than 25 years, Miltenyi Biotec has played an essential role in the biomedical research and cellular therapy community. Their innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, Miltenyi Biotec´s integrated technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Their expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. Today, Miltenyi Biotec has 2,000 employees in 25 countries.”



NGT-Partners is a private equity company that invests in Life-science companies with a strong and untapped value proposition for the Chinese market and with the potential to become innovation leaders in China.


Var2 Pharmaceuticals 

VAR2 Pharmaceuticals is a privately held biotechnology company engaged in the design and development of proprietary therapeutic proteins targeting cancer-specific carbohydrate structures for multiple cancer indications. We have a portfolio of proteins with unique affinity and specificity for these cancer-associated carbohydrates for the development of treatments for cancers where there is no effective therapy, such as sarcoma, triple negative breast cancers and prostate cancer.

VAR2 is also engaged in the development of cancer diagnostics, through its subsidiary VarCT Diagnostics.

Both the therapeutic as well as diagnostic technologies are based on groundbreaking discoveries made by researchers at University of Copenhagen, Denmark, in collaboration with partners at University of British Columbia, Canada.


Novozymes is a global biotechnology company headquartered in Bagsværd outside of Copenhagen, Denmark.  The company has operations in a number of countries around the world, including China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. The Novozymes class A share capital is held by Novo A/S, a wholly owned subsidiary of the Novo Nordisk Foundation. Class B shares of its stock are listed on the NASDAQ OMX Nordic exchange.

Novozymes is a world leader within research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. 





Life Science Academy – EasyB, deals with technical and scientific trainings and conferences for professionals involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related medical products. LS Academy, with its experience, provides a complete range of quality services dedicated to the pharmaceutical and CRO industry.

Life Science Academy offers an excellent expertise in the planning and organization of medical and scientific meetings with the collaboration of both national and international experts. LS Academy is a leader in its sector and offers its clients the necessary skills for continuous professional development, ensuring a competitive advantage

Sofus Regulatory Affairs AB 

As of January 2017, Sofus is a part of Xendo.

 Sofus was founded in 2002 and is the leading Nordic regulatory consultancy, supplying comprehensive regulatory, quality and safety solutions, to both multinational corporations and small businesses in the Nordics and in Europe. Xendo was founded in 1990 and is a leading consultancy and project management organisation in the 188金宝搏 , pharmaceutical and healthcare fields.

When the leading Nordic regulatory experts join forces with a leading consultancy and project management organisation, exciting things happen for our clients.

 From discovery to market

Together, Sofus and Xendo have established a unique and strong offer within Drug Development, Regulatory affairs and Quality Assurance. Our combined expertise enables a complete scope of consultancy services for your product’s life cycle.

Our consultants have extensive experience from managing global projects within drug development and regulatory affairs, as well as product portfolios for local markets.

In all stages through development and maintenance we offer expert services – assisting companies to live up to all requirements and being one step ahead when placing and keeping their products on the market.

We are used to collaborating with big pharma as well as small companies with the same dedication and accuracy.



Vectorbuilder is the world’s leading provider of vector construction and virus packaging services through its highly innovative online interactive platform To date, we have delivered over 110,000 vectors. 

VectorBuilder at a glance:

  • Free to use
  • 114,732 vectors delivered to date
  • 85 different types of vector backbones (Always expanding)
  • Expansive databases of vector components: promoters, ORFs, epitope tags, shRNAs and gRNAs.
  • 100% sequence guarantee
  • High quality downstream virus packaging, BAC modification, shRNA and gRNA library construction
  • Free design tool and/or click on ‘Send Design Request’ for more complex vectors
  • Rich annotation of vectors
  • Highly affordable price: typically, a fraction of what it would cost you to do it yourself (starting at 70GBP)
  • Rapid turnaround: within days





We are an innovative engineering consultancy dedicated to assist and manage projects within Manufacturing in the Life Science Industry. Our high calibre, well-trained team can provide customer-orientated solutions, whilst dealing with real-life constraints. The company fundamentals are based upon a good understanding of pharmaceutical/biotech manufacturing processes, quality assurance and technology transfer. Our main competency areas are Project Management, Consulting, Process Engineering, GMP Manufacturing Equipment, Medical Devices, Assembly and Packaging.


Patient Enrollment Service – fast delivery, motivated patients and cost-efficient services. Pay only per eligible patient.

Patiro is a patient enrollment service provider that offers a full-service patient enrollment solution with performance-based terms.

Our proven approach is inspired by data-driven efforts which allow us to reach, engage and communicate with patients and in turn deliver highly motivated patients in time. Our service is compliant with all relevant regulation, including the upcoming GDPR.




Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.


Immunahr AB was founded in Lund 2012 with the aim to develop AhR (aryl hydrocarbon receptor) agonists for the treatment of immune-related disorders, e.g. autoimmune diseases, and cancer. The most advanced project focuses on patent protected AhR-active metabolites of the clinical compounds laquinimod and tasquinimod. Research is driven by collaborations with external partners in academia and the pharmaceutical industry.

Methyl Detect


With a staff of more than 500 (290+ lawyers) employees, Kammeradvokaten/ Poul Schmith has grown to be one of Denmark’s largest and leading full-service law firms. The biotech team of of advisors is composed of specialists across our specialist teams in, inter alia, corporate/M&A, regulatory affairs, compliance and litigation. Consequently, Kammeradvokaten is able to provide highly specialised advice in all legal areas in relation to the biotech industry based on in-depth knowledge of the commercial reality in which the players in this industry operate.

Truly Labs – Your Preclinical Lab Partner

Truly Labs is a preclinical CRO providing tailor-made in vitro and in vivo services. Our services span from biomarker analysis to fully integrated pharmacology programs.

The in vivo team can support you with e.g. pharmacokinetic (PK) studies and customized efficacy (PD) models, PK/PD relationships and dose predictions, as well as in vivo imaging and state of the art inhalation services. Our in vitro capabilities include a wide range of cell-based assays, including Mode-of-Action and efficacy assays, biomarker analysis, genotyping, and proteomics.
We are flexible, committed and accommodate our customers’ needs. Some use Truly Labs as their internal lab while others benefit from our capabilities in specific studies.

Study design, performance, data evaluation, and reporting – with extensive knowledge and experience in drug development we can support the progression of your projects.

Bone Support AB
Our Vision is to be the world leader in the development and commercialization of injectable bio-ceramic composites that have both first-in-class bone remodeling and drug-eluting capabilities, for the management of bone voids and associated complications.
Our Mission is to improve the lives of patients suffering from bone disorders that cause bone voids, lead to injury, breakage, pain, and reduced quality of life.

AstraZeneca, Gothenburg

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection.

Our Gothenburg site is one of AstraZeneca’s three global strategic science centres. The teams located here have broad scientific expertise and capabilities, and work across the entire value chain of research and development with internal colleagues from other sites as well as academic and industry partners from all over the world.

Leymus Genomics

Leymus Genomics offers industry leading products and services for genomic analyses (NGS) for the Nordic countries and Germany. We are based in Copenhagen and founded and operated by employees coming from the NGS and Diagnostic industry.

Our core business areas:

NGS and Microarray service lab

We run samples in partnership with GenomeScan; ISO/IEC 17025 accredited leader in DNA analysis from sample to bioinformatics report. Illumina, PacBio and 10X platform validated service, industry leading turnaround time down to one week, and price competitive. Assays include transcriptomics, epigenetics, single cell sequencing, whole exome and full genome sequencing.

Large scale on site data storage for HPC

We offer data storage in partnership with DDN.

Approximately half of all large genomics centres globally use Data Direct 188金宝搏 (DDN) as their main data storage provider for sequencing applications, genomic pipelines and data collaboration solutions. We also provide large scale data storage for big data microscopy and systems biology.

Next Generation Sequencing library preparation

Leymus Genomics works with the company BioDynami, focusing on high-quality libraries, with industry leading short and simple library preparation time, minimizing hands on time.


SenzaGen is a spin out company from Lund University with expertise in immunology, technology and genomics. SenzaGen markets, sells and performs the in vitro GARD sensitization test through its own laboratory and through licenced CROs.

As a scientific quality-orientated and innovative international company, SenzaGen supports its clients with stringent quality assessments. The GARD test is recommended by ECHA and accepted by OECD for validation.


Immunicum is developing novel immuno-oncology therapies against a range of solid tumors. The approach is based on allogeneic dendritic cells that are designed to stimulate a personalized anti-tumor immune response in each patient. The Company’s lead compound, ilixadencel is currently being evaluated in clinical trials for the treatment of kidney cancer, liver cancer and gastrointestinal stromal tumors.


Link Logistics is a 100% Danish owned company with more than 15 years of experience in the courier transport business. Link Logistics offers globally integrated supply chain solutions within all types of transport. As the largest broker in Denmark, within the top 3 in Scandinavia, we are able to offer competitive rates to our customers. Link Logistics is a selected partner of some of the leading global courier companies, such as UPS, DHL and FedEx.

Link Logistics offers a flexible customer focused business concept which includes dimension measuring and weighing of all consignments. Focusing on easy-to-use IT solutions, Link Logistics continuously strives to improve and offer state-of-the-art IT integrated online booking site.

High security and quality
We offer door to door solutions worldwide through a carefully selected network of global partners. We ensure that your shipments arrive on time and keeps the right temperature along the way.

Please see our website for more information or contact Jonas Bay Kaas, Pharma Manager by mail: or phone + 45 3043 3773


Christians Hansen Health & Nutrition develop and produce products for dietary supplements, pharmaceuticals, infant formula and animal feed. Their key offering is probiotic cultures with documented effect for animals, humans and plants.


Ballerup is a leading municipality for business. It has Greater Copenhagen’s highest concentration of companies and jobs outside of Copenhagen itself. Greater Copenhagen is an area of interregional collaboration, bringing together the Capital Region of Denmark, Region Zealand and Skåne.
We have a diverse and strong business sector, featuring a unique mix of business types.






“ELPRO Nordic ApS, located in Roskilde west of Copenhagen, supports customers in Denmark, Sweden, Finland and Norway. ELPRO Nordic is a full affiliate of ELPRO-BUCHS AG Switzerland, an ISO 9001:2008 company with ISO 17025 accreditation for calibrations. ELPRO, founded in 1986, is a globally acting Swiss provider of innovative monitoring solutions specifically designed for the highly-regulated pharmaceutical, 188金宝搏 and healthcare industries. As a leader in these fields, ELPRO is a ‘full service’ organization offering state-of-the-art data loggers and indicators; stand-alone monitoring systems, cloud SaaS software platforms including data analytics; and a team of validation engineers to support technology integration into your business processes.

To best serve our customers, our staff is technically trained to provide application-based recommendations. As a result, we offer more than just a product, we provide turnkey solutions. Our specialist supports requests of all sizes – from monitoring just one piece of equipment to global all-inclusive projects requiring cold chain monitoring, thermal mapping, and facility monitoring systems. Whether you need an off-the-shelf product or a custom solution, our technical staff and nationwide sales team fully support you through the entire process of product recommendation, training, and implementation.

Please see our website for more information: or contact Søren Helmer Nielsen, General Manager by mail: or phone + 45 2220 2620”

ELPRO – we prove it.




AMMACE Consulting AB

Emmace Consulting offers excellence in advising and performance testing of pharmaceutical products on a CRO-basis.


ImmuneBiotech AB discovers and develops novel microbiome therapeutics based on probiotic lactic acid bacteria and synbiotic formulations targeting the gut microbiota and the immune system.

Link Medical Research

LINK Medical is a full-service contract research organization (CRO) providing product development services for the pharmaceutical and medical device industries across Northern Europe. 

We offer a well-integrated local presence in the Nordics, UK, and Germany. Reaching from early phase development to post-marketing, we have over 180 employees providing expert guidance across every aspect of a project – all from ONE source.  Our specialized oncology team thrives with complex oncology studies due to our broad multidisciplinary knowledge and long experience overcoming the associated challenges at every step.

Our promise is to improve and accelerate your product development through transformative methods, active communication and optimal solutions. As a strategic partner, we provide expert competence and technology to enable evidence-based decision-making that support the delivery of superior clinical outcomes.

Network objective
Become available as a strategic partner for small to mid-size Life Science Companies from innovation to post-marketing

Stay updated and share cutting-edge innovations with the industry

Lena Lindeberg, Director, Commercial Operations, LINK Medical,  Lena.lindeberg [at]

Gedea Biotech

Gedea Biotech develops antibiotic-free and safe local treatments of bacterial and fungal infections. Gedea Biotech’s substance, GA101, is a natural substance that has always been part of our environment and is approved as a food additive. It acts by a novel mechanism that prevents and treats infection in depth by inhibiting the formation of biofilm. Due to the novel mode of action it has a reduced risk of inducing treatment resistance. The first product will be a slow-release pessary for treatment and prevention of vaginal fungal infections to be market launched in 2019/2020 as an OTC.


Follicum develops drugs that can both stimulate and inhibit hair follicle activity.
Independent in-vitro and in-vivo studies on living human skin tissue show that Follicum’s candidate drug is effective in inhibiting hair growth, while exhibiting no side effects.
In comparable in vivo studies in mice, one of Follicum’s drug candidates stimulated hair growth significantly faster, and produce hair growth over a much larger area than minoxidil (the active ingredient in Rogaine®).




ICONOVO is a Swedish privately funded device company with a business model to supply the market with unique, safe and cost efficient inhalation products. ICONOVO has long and unique experience and capability in the development of inhalation devices and formulations. ICONOVO’s products combine technical complexity with user friendly and attractive design. ICONOVO’s ambition is to become a leading supplier on a global market.



SOLVE is a CRO specialized in material characterisation.

We have world-leading competence in separation and characterization methods, for example the state-of-the-art technique asymmetric flow field-flow fractionation. This technique is highly suitable for standard and challenging materials and can provide superior additional/complementary information to conventional techniques.

We have experience in analysing non-biological materials such as plastics, metals as well as peptides, macromolecules, aggregates, formulation excipients, polysaccharides, emulsions, and more – assessing properties such as molar mass, composition, surface chemistry, shape etc.


At Speximo we have created a technique derived from nature that enable water-oil emulsion without the use of surfactants or synthetic emulsifiers.

Our patented technology is the result of international collaborations and applied research based on the exceptional Pickering particle properties of quinoa. We can now provide the cosmetic, food, and pharmaceutical industry with an environmentally sustainable mechanism for emulsion stabilization (EQMULSE), or encapsulation of active ingredients (EQLIPSE). The end-product is proven safe for sensitive skin and delivers a smooth, silky texture with a non-residual feeling. In our laboratory, our dedicated team continuously explore new applications and solve formulation problems for customers all over the world.


SmiLe is a 188金宝搏 business incubator based in Medicon Village in Lund, Sweden, that offers business development services to entrepreneurs to help them develop and commercialize their ideas. The incubator offers a unique infrastructure with well-equipped laboratories – cell and bacterial culturing, protein purification, chemical and biochemical analyses, in total at 1,700 m2 area – and operates in an environment of 188金宝搏 companies in various phases of development, with a variety of experts and investors. SmiLe receives basic funding from Region Skåne, Lund Municipality, Lund University and Medicon Village.

  • Facts about SmiLe companies:
  • SmiLe’s incubator and alumni companies have together attracted more than SEK 1,000 million in venture capital since 2014.
  • There are currently almost 25 companies at SmiLe that together have about 100 employees from 17 different nations. Over 40 percent are women.
  • Eight of SmiLe’s 20 alumni companies are listed on AktieTorget or Nasdaq First North.
  • The companies covers business areas such as therapy, diagnosis, drug delivery, stem-cells, medtech, nanotech, digital health, bio-greentech and expert research service.

Contact us at:; LinkedIn, Twitter and Facebook.


Semcon is an international technology company that develops products based on human needs and behaviours. We strengthen our customers’ competitiveness by always starting from the end user, because the person who knows most about the user’s needs creates the best products and the clearest benefits to humans. Semcon collaborates mainly with companies in the automotive, industry, energy and 188金宝搏 sectors. With more than 2000 specialised employees, Semcon has the ability to take care of the entire product development cycle, from strategy and technology development to design and product information.
Semcon was founded in Sweden in 1980 and has offices in over 30 locations in eight different countries. In 2016, the Group reported annual sales of SEK 1.8 billion. 


Probiotics have been part of the human diet for millennia and are found naturally in foods like pickled cucumbers, olives, sauerkraut, salami, yoghurt and sour milk. Many probiotic bacteria belong to the Lactobacillus or Bifidobacteriumgenuses. These are harmless and occur naturally in the gastrointestinal tract of humans and animals.


The composition of the gastrointestinal microflora is very important to our health. Disturbing the balance between “good” and “bad” bacteria may cause health problems and serious diseases. Probiotics help to balance the intestinal flora, which can result in a healthier digestive system and a strong immune system. As knowledge increases about how a better diet can prevent future medical problems, so too does the interest in probiotics.

We invite you to learn more about our probiotics and the research that supports them.

The World Health Organization defines probiotics as “live micro-organisms which, when administered in sufficient amounts, confer a health benefit on the host”.


SidekickHealth was founded by two practicing physicians, Tryggvi “Thor” Thorgeirsson, M.D., MPH, and Saemundur “Sam” Oddsson, M.D., to predict and prevent lifestyle-related diseases. Recognizing that traditional methods of counseling for lifestyle change were not effective enough to bring about the massive shift needed to reverse the global epidemic of chronic illness, these two founders brought together a team of physicians, psychologists, public health scientists, biomedical engineers and game developers, and drew on the latest research from leading academic and medical institutions in the U.S. and Europe. 

The result is SidekickHealth, a highly engaging, gamified service and app featuring programs for diet, physical activity and stress management. The platform is designed to reach those who are in greatest need of lifestyle change, including the 50 percent of adults who have low health literacy, and people with low motivation for lifestyle change. SidekickHealth also helps diabetes prevention programs and chronic disease management programs lower operational costs, improve outcomes and increase value-based reimbursements.



I Pfizer Danmark ønsker vi gennem vores sundhedsfaglige aktiviteter at bidrage til udviklingen af et stærkt dansk sundhedsvæsen. Det kan kun ske i dialog og samarbejde med relevante parter som læger, hospitaler, kommuner, regioner, politikere, medier m.fl.

Pfizers virksomhed i Danmark spænder over en bred vifte af sundhedsfaglige kompetencer, som danner det samlede billede af, hvad vi arbejder med.


AddLife is a group that comprises approximately 25 operating subsidiaries that mainly operates in the Nordic Life Science market. The Life Science market can be divided in larger market areas, where the group primarily focuses in selected niches in the market areas diagnostics, medical technology and biomedical research and laboratory analysis.  AddLife has operates in two business areas; Labtech and Medtech. The business area Labtech focuses on sales to the two market areas of diagnostics and biomedical research and laboratory analysis while Medtech focuses on sales to the market area medical technology. AddLife is, except from the operations in the Nordic countries, also represented by smaller businesses on the European market in Germany, the Benelux countries, Estonia and Italy.


Symphogen is a leading clinical stage antibody oncology-focused company with a differentiated monoclonal antibody, or mAb, mixture product pipeline with significant clinical potential and commercial opportunities. The company’s novel biologic approach is uniquely designed to address tumor diversity and resistance by combining multiple antibodies in a single drug product.

GAEU Consulting

GAEU Consulting has written the winning SME Instrument Phase 2 applications for the Swedish 188金宝搏 companies Immunovia, SymCel, Ilya Pharma, Scandinavian Biopharma, Verigraf, Idogen, Corline Biomedical, Senzagen, Opsis, Clinical Laserthermia Systems and Betagenon. GAEU Consulting is an EU grant consultancy specialized in the Horizon 2020 SME Instrument programme and other types of national and international public innovation funding. The firm combine high academic standards with strong business acumen. See complete reference list at our webpage 



Biokinetic Europe

BioKinetic Europe is an independently owned clinical research organisation (CRO). Established in 1996, BioKinetic has developed a reputation as a leading European early phase clinical pharmacology unit. BioKinetic has its primary operation in Belfast, Northern Ireland but with many of its Sponsors being based in the Medicon Valley region, they have established a secondary infrastructure in the greater Copenhagen area including a dedicated office space and selection of local CRAs.

BioKinetic’s core specialism lies in the design and meticulous conduct of adaptive study protocols (Phase I-III), from First-in-Man to Proof-of-Concept across a range of therapeutic areas including Diabetes, Women’s Health, Vaccines, Ophthalmology and Respiratory.

Their Phase I CPU in Belfast, Northern Ireland, which recently implemented a new Electronic Data Capture (EDC) system has held MHRA Supplementary Accreditation since 2009, a symbol that demonstrates their ongoing commitment to provide the industry’s highest standards of volunteer safety and data integrity. BioKinetic is an approved training unit for the Faculty of Pharmaceutical Medicine’s Diploma course with all Research Physicians enrolled on the programme.


Teknologisk Institut

The Life Science division at Danish Technological Institute (DTI) provides novel solutions to a wide range of obstacles in pharma, bio- and medtech.

At DTI the overall mission of Life Science is to challenge the status quo by inventing outstanding technological solutions in cooperation with clients, technology providers, hospitals, end-users, and universities.

Our Life Science division is rather unique as it gives our clients access to a range of platforms and technologies for testing, analysing, and characterization. We have specialists in physics, biology, chemistry, molecular biology, engineering, etc, who can find or develop the right solutions that are customised to meet the individual client´s needs and requirements.

We fx test coatings and materials using in vitro analyses, optimise cleaning procedures for reusable medical devices, test autoclaving systems for medical equipment, and validate products for improved wound treatment.

We are experienced in using genomics, transcriptomics, and proteomics data for applied R&D, e.g., when investigating infection and drug mechanisms and performing drug target deconvolution. We have also contributed significantly to the development of market-ready diagnostic assays for patient stratification.

The diversity of our competences reflects the great variation in the type of tasks and challenges that we can manage for 188金宝搏 .



PledPharma is a Swedish pharmaceutical company developing new drugs that protect the body against oxidative stress – a potentially disabling and sometimes life-threatening condition that can be caused by for example chemotherapy treatment or acetaminophen (paracetamol) overdose. The company’s most advanced project PledOx® reduces nerve damage associated with chemotherapy treatment. Positive results from phase IIb study PLIANT were presented in the spring of 2015 with follow-up and survival data presented during 2016. Phase III studies are planned to start during 2017. The drug candidate Aladote® is developed to reduce the risk of acute liver failure associated with acetaminophen overdose. Proof-of-principle clinical studies are planned to start 2017.

PledPharma (STO:PLED) is listed on Nasdaq First North

Agnitio A/S

Digital Customer Experience  – Technology Partner for the Global Life Science Industry

Agnitio A/S is specialized in the 188金宝搏 industry, partnering with the world’s leading pharmaceutical, medical device, consumer health and animal health companies.

With our innovative digital communication services & solutions, we have become a trusted and preferred partner with major 188金宝搏 companies like Amgen, Bayer, Philips, and Roche contributing to major successes on their digital transformation journey.

Agnitio A/S is able to accelerate your digital evolution generating strong customer insights and delivering a proven customer experience throughout the value chain. Agnitio A/S matches state of the art healthcare communication technology with professional services to activate and maximize the effectiveness of your Digital & Multichannel Sales & Marketing Strategy.



Medicollect is a service provider specialized in patient recruitment for clinical trials. We are offering faster, safer and more reliable supply of qualified and pre-screened patients for clinical trials within all diseases. Clients are pharma, biotech and CROs in Denmark, Sweden and the UK. Our clients avoid delays and costs of opening more sites. Medicollect operates large proprietary databases of volunteers and qualify patients for studies via own study nurses performing telephone pre-screening, which means low work burden for site teams and high probability of enrolment. Medicollect only charges a fixed price per randomised patient.


UL Compliance to Performance

For over 30 years, UL Compliance to Performance has provided solutions to many of the world’s leading Life Science companies. Our comprehensive compliance and quality management approach integrates technology, content and professional services, designed specifically to help clients in the Life Science Industry evolve from Compliance to Performance as they market their products to the US and the EU. We provide solutions based from a combination of advisory solutions delivered by local SME’s and a strong modular SaaS/Cloud technology platform that features ComplianceWire®, our 21 CFR and Annex 11-validated fully scalable Learning Management System. Our clients benefit from the same Learning Management Technology that we partner with the US FDA to train over 35,000 investigators globally.

UL is a premier global independent safety science company that has championed progress for 120 years. It’s more than 12,000 professionals are guided by the UL mission to promote safe working and living environments for all people.


NDA Group, the world’s leading drug development consultancy.

We support 188金宝搏 companies all over the world with the single aim to streamline the global development and commercialization process in order to accelerate patient access to important medical therapies.

NDA comprises over 150 dedicated consultants with industry and regulatory agency backgrounds, supported by a network of over 1 000 scientific, clinical, regulatory and drug development experts. Our advice covers all phases of development and all major therapeutic areas. With our support you can cut the time and cost it takes to get your product to the patients that need them.



Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving people’s quality of life by preventing, alleviating and treating diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.


Immunitrack is specialized  in next generation MHC-peptide  technologies for best-in-class in vitro peptide immunogenicity assessment for optimized biologics, vaccines and immunotherapies. New ways of measuring and preparing MHC-peptide complex are provided to ensure cost-effective development of best-in-class biologic therapeutics.

Immunitrack was established in 2013, and its expertise has been validated through more than a decade of academic research.  Companies that already benefit from Immunitrack’s platform technology include notable top 20 pharmaceutical and biotech companies.

Sedermera Fondkommission

Sedermera Fondkommission offers services for listed companies or companies with the target of being listed at a trading platform. Sedermera’s services includes corporate finance, certified adviser, M&A’s, financial communications, issue management and market making. Sedermera is a secondary name of ATS Finans AB, an investment firm under the supervision of the Swedish FSA (Finansinspektionen). Sedermera’s headquarter is in Malmö, Sweden.


MultiHelix AB is a company working in the intersection of 188金宝搏 , information and communication technology and food tech. We are a company with a strong mission to create value for people’s health and well being by utilising knowledge for sustainable growth and welfare. 

London, UK

The Danish-UK Chamber of Commerce (DUCC) was founded on 23 August 1989 by the Danish Embassy and prominent business people in London, and was initially set up to enhance the Anglo-Danish marketplace through networking.

To this day, the DUCC’s core mission is “To promote business, trade and investment between Denmark, the UK and internationally”

We do this through events, monthly newsletters where we encourage our members to take an active part and sending us their contributions ie company news, press releases, event invitations, new employments.

The DUCC is a networking based non-profit organisation. To give members, companies and individuals an opportunity to network and benefit from each other, the Chamber is on average hosting 25-35 events throughout the year at which prominent speakers from the worlds of business and politics are invited. Topics are carefully selected to be of interest to the Danish, British and wider international business community.

DIS -Study Abroad in Scandinavia
Copenhagen, Denmark

DIS is a non-profit study abroad foundation established in Denmark in 1959, with locations in Copenhagen and Stockholm. DIS provides semester, academic year, and summer programs taught in English, and offers high-impact learning experiences for upper-division undergraduate students from distinguished North American colleges and universities. The intellectually challenging curriculum is broad, cutting edge, and enriched by experiential learning components, including faculty-led study tours across Europe. The housing and extracurricular offerings provide students with opportunities for meaningful cultural engagement and personal growth.